Amedeo Smart

Free Medical Literature Service

 

Amedeo

Drug Resistance
  Free Subscription

Articles published in
J Antimicrob Chemother
    March 2026
  1. PAUW HS, Schwarz R, Beij A, Sieswerda E, et al
    Antimicrobial therapy for infected necrotizing pancreatitis: microbiology, antimicrobial resistance and pharmacokinetics.
    J Antimicrob Chemother. 2026;81:dkag092.
    >> Share

  2. SCHONENBERGER CM, Haenggi K, Ringera IK, Luoga E, et al
    HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial.
    J Antimicrob Chemother. 2026;81:dkag070.
    >> Share

  3. KOIZUMI J, Otake R, Seyama S, Hayashi N, et al
    Functional analysis of a novel macrolide-lincosamide resistance gene erm(57) in Cutibacterium avidum.
    J Antimicrob Chemother. 2026;81:dkag029.
    >> Share

  4. GRAZIANI L, Giani T, Farese A, Di Lauria N, et al
    Vancomycin resistance predicts increased mortality in patients with Enterococcus faecium bloodstream infections: a six-year experience at a large tertiary care Italian hospital.
    J Antimicrob Chemother. 2026;81:dkag069.
    >> Share

    February 2026
  5. KARAKONSTANTIS S, Tziolos RN, Paneta M, Kritsotakis EI, et al
    Global and regional prevalence of metallo-beta-lactamases in carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2026;81:dkag037.
    >> Share

  6. THORINGTON R, Barairo N, Peterson SW, Lourenco L, et al
    Summary of ceftriaxone-resistant Neisseria gonorrhoeae in Canada, 2017-24.
    J Antimicrob Chemother. 2026;81:dkag007.
    >> Share

  7. VAN OSCH JAT, Voermans JJC, Ouzerne H, Cromme ABH, et al
    Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure.
    J Antimicrob Chemother. 2026;81:dkag033.
    >> Share


  8. Correction to: Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
    J Antimicrob Chemother. 2026;81:dkaf494.
    >> Share

  9. ELBUR AI, Gandla S, Nakka R, Khan R, et al
    Nationwide patterns of HIV drug resistance and high viral load in Sub-Saharan African countries.
    J Antimicrob Chemother. 2026;81:dkaf497.
    >> Share

  10. CHEN S, Wei Y, Wang Q, Li Y, et al
    Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).
    J Antimicrob Chemother. 2026;81:dkag016.
    >> Share

  11. XIA X, Ge M, Chen J, Qian X, et al
    LYSC98 as a novel vancomycin-derived agent effective against antibiotic-resistant pathogens in tolerant state.
    J Antimicrob Chemother. 2026;81:dkag036.
    >> Share

  12. CIACCIO L, Donnan PT, Parcell BJ, Marwick CA, et al
    Impact of COVID-19-related healthcare changes on antibiotic resistance in clinical Escherichia coli isolates: interrupted time series analyses in Scotland, UK.
    J Antimicrob Chemother. 2026;81:dkag049.
    >> Share

  13. ROTUNDO S, Russo A, Morena R, Garofalo E, et al
    Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study.
    J Antimicrob Chemother. 2026;81:dkag056.
    >> Share

  14. KIM SH, Kim HM, Chung DR, Ko JH, et al
    In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
    J Antimicrob Chemother. 2026;81:dkag031.
    >> Share

  15. FAN Y, Liang X, Ren Y, Nie S, et al
    A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2026;81:dkag061.
    >> Share

  16. PEZZATI L, Conti F, Gennari W, Mussini C, et al
    Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.
    J Antimicrob Chemother. 2026;81:dkag035.
    >> Share

  17. ISLAM R, Das SC, Pletzer D
    Combating multidrug-resistant Klebsiella pneumoniae: current therapeutic regimens and future directions.
    J Antimicrob Chemother. 2026;81:dkag064.
    >> Share

  18. QIN L, Xie Y, Li J, Zhong G, et al
    Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China.
    J Antimicrob Chemother. 2026;81:dkag073.
    >> Share

    January 2026
  19. COLE MJ, Doumith M, Vickers A, Alexander S, et al
    In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates.
    J Antimicrob Chemother. 2026;81:dkag001.
    >> Share

  20. CHEN GJ, Lee NY, Tsai MS, Huang SH, et al
    Resistance to second-generation integrase inhibitors in people with HIV following treatment failure on dolutegravir- or bictegravir-based ART in Taiwan.
    J Antimicrob Chemother. 2026;81:dkaf488.
    >> Share

  21. SWEENEY EL, Tickner JA, Ertl NG, Bauer MJ, et al
    Rapid molecular diagnostics for detection of extensively drug-resistant Salmonella Typhi.
    J Antimicrob Chemother. 2026;81:dkaf481.
    >> Share

  22. WU M, Li J, Zhou Z, Chen Y, et al
    Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf504.
    >> Share

  23. STURM PDJ, Van Niekerk JM, Lestrade PPA, Peters CJA, et al
    Prevalence of macrolide resistance in Mycoplasma pneumoniae in The Netherlands.
    J Antimicrob Chemother. 2026;81:dkaf475.
    >> Share

  24. DWIBEDY SK, Padhy I, Mohapatra SS
    A comprehensive analysis of the mutational landscape determining polymyxin resistance in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf503.
    >> Share

  25. ZHUO J, Xu J, Chi Y, Zhang N, et al
    Ceftazidime/avibactam: a potent arsenal against multidrug-resistant Pseudomonas aeruginosa-unveiling in vitro and in vivo strategies.
    J Antimicrob Chemother. 2026;81:dkaf495.
    >> Share

  26. MIELKO-NIZIALEK KA, Jablonski S, Wisniewski J, Milczewska J, et al
    Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis.
    J Antimicrob Chemother. 2026;81:dkaf453.
    >> Share

  27. SAAD BAA, Volpe-Chaves CE, de Oliveira CTF, Conte BS, et al
    The emerging clinical relevance and antimicrobial resistance of Pluralibacter gergoviae: a systematic review.
    J Antimicrob Chemother. 2026;81:dkaf476.
    >> Share

  28. TASCINI C, Bianco G, Bonomo RA, Gaibani P, et al
    In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf467.
    >> Share

  29. MCCRACKEN M, Lerminiaux N, Adam HJ, Baxter M, et al
    Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.
    J Antimicrob Chemother. 2026;81:dkaf478.
    >> Share

  30. ZHANG X, Xie Y, Liu F, Cheng Z, et al
    Simulated lung exposure in pneumonia patients to evaluate the antibacterial capacity and resistance suppression of clinical tigecycline regimens against carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2026;81:dkaf477.
    >> Share

  31. TU NQ, Montrouge T, Mbemba G, Stampetta M, et al
    First characterization of insertions in the HIV-1 integrase-coding region from people with HIV.
    J Antimicrob Chemother. 2026;81:dkaf491.
    >> Share

  32. YAMANO Y, Takemura M, Longshaw C, DeJonge BLM, et al
    Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2026;81:dkag004.
    >> Share

  33. LI Y, Dong H, Liu X, Shen Y, et al
    IS26-mediated chromosomal integration of virulence plasmid fragments in ST2237 carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkag018.
    >> Share

  34. MARTINEZ-BUITRAGO E, Zapata-Marin AF, Rubiano LC, Sanudo LM, et al
    National representative survey of pretreatment HIV drug resistance in Colombia: analysis of antiretroviral resistance-associated mutations using next-generation sequencing.
    J Antimicrob Chemother. 2026;81:dkaf444.
    >> Share

  35. AHLSTRAND J, Maatouk I, Doanh LH, Girdthep N, et al
    High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24.
    J Antimicrob Chemother. 2026;81:dkaf452.
    >> Share

  36. MONTERO MM, Fernandez-Munoz A, Domene-Ochoa S, Castaneda S, et al
    Preventing resistance development in infections by OXA beta-lactamase-producing Pseudomonas aeruginosa: correlating clinical outcomes with hollow-fibre model input.
    J Antimicrob Chemother. 2026;81:dkaf464.
    >> Share

  37. KAPAATA A, Byamukama D, Kankaka EN, Asio JN, et al
    HIV-1 drug resistance among pregnant and breastfeeding mothers and its association with paediatric HIV infections in the Dolutegravir era in Uganda.
    J Antimicrob Chemother. 2026;81:dkaf411.
    >> Share

  38. MELNYCHUK S, Thompson LH, Archibald C, Blanchard JF, et al
    Notable transmitted HIV drug resistance among people who inject drugs in Pakistan.
    J Antimicrob Chemother. 2026;81:dkaf425.
    >> Share

  39. RAAIJMAKERS J, Aarnoutse R, Te Brake L, Stemkens R, et al
    Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system.
    J Antimicrob Chemother. 2026;81:dkaf402.
    >> Share

  40. MUDDE SE, Meliefste HM, Klaassen CHW, Ammerman NC, et al
    Omadacycline as a drug candidate for Mycobacterium avium infections: in vitro insights on single and combination therapies.
    J Antimicrob Chemother. 2026;81:dkaf413.
    >> Share

  41. SOULIE C, Agher R, Fauchois A, Abdi B, et al
    Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable.
    J Antimicrob Chemother. 2026;81:dkaf454.
    >> Share

  42. SHAW D, Thakur S, Ghosh A, Dogra S, et al
    Efflux-mediated multidrug resistance mechanism in Trichophyton indotineae and Trichophyton rubrum; role of ABC transporters and MFS gene.
    J Antimicrob Chemother. 2026;81:dkaf434.
    >> Share

  43. MOSTAFA R, Mohammed S, Ahmed AS, Aly SA, et al
    Nanoparticle-based co-delivery of ciprofloxacin and meropenem enhances synergistic activity against multidrug-resistant hypervirulent Klebsiella pneumoniae clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf422.
    >> Share

  44. VERMA S, Tilak R, Singh G, Singh S, et al
    Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights.
    J Antimicrob Chemother. 2026;81:dkaf420.
    >> Share

  45. ANDERSSON M, Zimmermann N, Kloft C, Aulin LBS, et al
    Antibiotic pharmacodynamics: from MIC to advanced metrics and their applications.
    J Antimicrob Chemother. 2026;81:dkaf374.
    >> Share

  46. PALICH R, Ghosn J, Lacombe K, Palacios C, et al
    Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
    J Antimicrob Chemother. 2026;81:dkaf410.
    >> Share

  47. ZHANG Y, Zhang X, Han S, Wang D, et al
    Progress in the study of drug resistance mechanism of Bacillus cereus.
    J Antimicrob Chemother. 2026;81:dkaf399.
    >> Share

  48. ZHU Z, Hua X, Ke Y
    Azithromycin resistance in non-typhoidal Salmonella: a review.
    J Antimicrob Chemother. 2026;81:dkaf341.
    >> Share

    December 2025
  49. ZHAO R, Wan P, Huang H, Li Q, et al
    Harnessing CRISPR-Cas9 and CRISPRi systems to reverse antibiotic resistance in a clinical multidrug-resistant Escherichia coli isolate.
    J Antimicrob Chemother. 2025 Dec 24:dkaf442. doi: 10.1093.
    >> Share

  50. ASIM M, Rizvi SA, Haq QMR
    Antiplasmid systems: a novel strategy to combat antibiotic resistance.
    J Antimicrob Chemother. 2025 Dec 19:dkaf472. doi: 10.1093.
    >> Share

  51. KUIL S, Bavalia R, Boyd A, de Jong M, et al
    Local antibiotic resistance surveillance in nursing homes using lot quality assurance sampling: a feasibility study.
    J Antimicrob Chemother. 2025 Dec 17:dkaf451. doi: 10.1093.
    >> Share

  52. CANAS MA, Cuervo G, Garcia-Gonzalez J, Krivak F, et al
    In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis.
    J Antimicrob Chemother. 2025 Dec 4:dkaf435. doi: 10.1093.
    >> Share

  53. CHAUVIN C, Jouy E, Chevance A, Jaureguy C, et al
    Decrease in colistin resistance among young bovine and pig productions in France: relationship with colistin usage and stewardship measures.
    J Antimicrob Chemother. 2025;80:3227-3235.
    >> Share

  54. ZHANG H, Liang B, Tan Z, Wang R, et al
    The synergistic activity of tigecycline-based combinations against multidrug-resistant Acinetobacter baumannii-caused bloodstream infections.
    J Antimicrob Chemother. 2025;80:3407-3418.
    >> Share

  55. VAN RHIJN N, White PL
    Antifungal treatment strategies and their impact on resistance development in clinical settings.
    J Antimicrob Chemother. 2025;80:3208-3226.
    >> Share

  56. MULLER SE, Junker S, Rehner J, Forster M, et al
    Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2025;80:3352-3356.
    >> Share

  57. PELLEGRINO C, Veronese N, De Santis L, Amendolara A, et al
    Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2025;80:3257-3264.
    >> Share

  58. MORAN RA, Hall RM
    The aphA1 kanamycin and neomycin resistance gene originated in Klebsiella michiganensis.
    J Antimicrob Chemother. 2025;80:3340-3344.
    >> Share

  59. CASADO JL, Blanco JL, Izuzquiza I, Moreno A, et al
    From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.
    J Antimicrob Chemother. 2025;80:3242-3247.
    >> Share

  60. BLANCO-MARTIN T, Guzman-Puche J, Hernandez-Garcia M, Munoz-Rosa M, et al
    Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes.
    J Antimicrob Chemother. 2025;80:3265-3272.
    >> Share

  61. SEHGAL N, Pajuelo MJ, Gilman RH, Pickering AJ, et al
    Effects of commonly used antibiotics on children's developing gut microbiomes and resistomes in peri-urban Lima, Peru.
    J Antimicrob Chemother. 2025;80:3248-3256.
    >> Share

  62. TANG B, Hu X, Song Y, Liu X, et al
    Acquired antimicrobial resistance genes in Bordetella Species: a global genomic analysis.
    J Antimicrob Chemother. 2025 Dec 1:dkaf418. doi: 10.1093.
    >> Share

    November 2025
  63. TORUMKUNEY D, Mokaddas E, Weber S, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  64. TORUMKUNEY D, Van PH, Thinh LQ, Hawser S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2020-21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  65. TORUMKUNEY D, Veeraraghavan B, Patil N, Dias M, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in India: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  66. TORUMKUNEY D, Keles N, Hasdemir U, Hazirolan G, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Turkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  67. TORUMKUNEY D, Slim L, Hammami A, Hawser S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Tunisia: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  68. TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  69. TORUMKUNEY D, Nizamuddin S, Morrissey I, Manenzhe R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  70. TORUMKUNEY D, Canton R, Pitart C, Sanguinetti M, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    >> Share

  71. MIN P, Yao J, Ruan S, Zhou L, et al
    Global phylogeography and genomic characterization of blaNDM-1-positive carbapenem-resistant Acinetobacter soli.
    J Antimicrob Chemother. 2025 Nov 24:dkaf437. doi: 10.1093.
    >> Share

  72. JOHNSON A, Madec JY, Pournaras S
    JAC Supplement: Survey of Antibiotic Resistance (SOAR) results 4-respiratory pathogen susceptibility.
    J Antimicrob Chemother. 2025;80.
    >> Share

  73. BENSACI MF, Bauer KA, Klinker K, Cota J, et al
    Post-pandemic trends in Streptococcus pneumoniae serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022-2023).
    J Antimicrob Chemother. 2025 Nov 20:dkaf414. doi: 10.1093.
    >> Share

  74. ALMEIDA-SANTOS AC, Tedim AP, Duarte B, Silva LM, et al
    Unnoticed spread of linear VanA-plasmids in vancomycin-variable Enterococcus faecium strains across different regions: a diagnostics challenge.
    J Antimicrob Chemother. 2025 Nov 20:dkaf409. doi: 10.1093.
    >> Share

  75. MANSOURI A, Durazzi F, Ihsan MA, Griffin S, et al
    Identification of antimicrobial resistance genes in Escherichia coli through network diffusion.
    J Antimicrob Chemother. 2025 Nov 11:dkaf404. doi: 10.1093.
    >> Share

  76. LU R, Li X, Yang W, Chen J, et al
    In vitro activity of contezolid and other comparators against clinical Staphylococcus and Enterococcus: a multicenter study in China.
    J Antimicrob Chemother. 2025;80:3011-3020.
    >> Share

  77. DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
    High level of archived and circulating HIV-1 drug resistance mutations in adolescents with a detectable viremia in Cameroon.
    J Antimicrob Chemother. 2025;80:3160-3164.
    >> Share

  78. TOEPFER S, Lamping E, James JE, Zenz LM, et al
    Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus.
    J Antimicrob Chemother. 2025;80:3065-3078.
    >> Share

  79. GILBERT M, Ferre VM, Guilbaud R, Digumber M, et al
    How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy?
    J Antimicrob Chemother. 2025;80:3133-3138.
    >> Share

  80. ARMENIA D, Marchegiani G, Spagnuolo V, Bellocchi MC, et al
    Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.
    J Antimicrob Chemother. 2025;80:3101-3106.
    >> Share

  81. TOYTING-HIRAISHI J, Sato T, Tohyama M, Fujino T, et al
    Potential human health risk of carbapenem-non-susceptible Pseudomonas aeruginosa from companion animals.
    J Antimicrob Chemother. 2025;80:3043-3056.
    >> Share

  82. GRAFIA I, Moll-Febrer A, Santillan SJ, Rodrigo C, et al
    Multidrug resistance and recurrence in urinary bacteraemia among cancer patients.
    J Antimicrob Chemother. 2025;80:3026-3033.
    >> Share

  83. CHUA TP, Huaman JL, Danielewski J, Bradshaw CS, et al
    In vitro evolution provides insights into mechanisms of Mycoplasma genitalium resistance to moxifloxacin.
    J Antimicrob Chemother. 2025;80:2970-2977.
    >> Share

  84. JIANG X, Cao D, Qiu Y, Dong X, et al
    Novel mutations associated with clofazimine resistance in Mycobacterium intracellulare.
    J Antimicrob Chemother. 2025;80:2954-2957.
    >> Share

  85. BOYD SE, Wootton M, Howe RA, Livermore DM, et al
    Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
    J Antimicrob Chemother. 2025 Nov 3:dkaf392. doi: 10.1093.
    >> Share

    October 2025
  86. REYNOLDS R, Mushtaq S, Hope R, Horner C, et al
    Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
    J Antimicrob Chemother. 2025;80.
    >> Share

  87. REYNOLDS R, Felmingham D, Mushtaq S, Horner C, et al
    Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019.
    J Antimicrob Chemother. 2025;80.
    >> Share

  88. REYNOLDS R, Mushtaq S, Hope R, Horner C, et al
    Antimicrobial resistance among Gram-positive agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
    J Antimicrob Chemother. 2025;80.
    >> Share

  89. REYNOLDS R, Morrissey I, Mushtaq S, Horner C, et al
    Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019.
    J Antimicrob Chemother. 2025;80.
    >> Share

  90. HORNER C, Reynolds R, Mushtaq S, Chaudhry A, et al
    Trends of serotypes and resistance among Streptococcus pneumoniae in the UK and Ireland (1999-2019).
    J Antimicrob Chemother. 2025;80.
    >> Share

  91. MACGOWAN AP, Reynolds R, Parcell BJ, Livermore DM, et al
    Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions.
    J Antimicrob Chemother. 2025;80.
    >> Share

  92. PARCELL BJ, Horner C, Reynolds R, Allen M, et al
    Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future.
    J Antimicrob Chemother. 2025;80.
    >> Share

  93. ALLEN M, Reynolds R, Mushtaq S, Nsonwu O, et al
    The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: methods and limitations.
    J Antimicrob Chemother. 2025;80.
    >> Share

  94. CHOWDHURY FR, Findlay BL
    Sequential antibiotic exposure restores antibiotic susceptibility.
    J Antimicrob Chemother. 2025 Oct 8:dkaf350. doi: 10.1093.
    >> Share

  95. LAI CC, Liu CY, Huang KJ, Huang YT, et al
    Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
    J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
    >> Share

  96. HSU CH, Li C, Harrison L, Zhao S, et al
    Genomic structure of class 1 and 2 integrons in non-typhoidal Salmonella isolated from food animals and related meat products in the USA.
    J Antimicrob Chemother. 2025;80:2844-2853.
    >> Share

  97. YANG J, Jiang T, Zhang M, Xue J, et al
    Phenotypic and genotypic profiles of clinical isolates of various Nocardia species to carbapenems and fluoroquinolones.
    J Antimicrob Chemother. 2025;80:2862-2872.
    >> Share

  98. LARKIN C, Valappil SP, Palanisamy N
    Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2025;80:2609-2621.
    >> Share

  99. HALIM J, Keane AP, Bouzo J, Aderibigbe T, et al
    Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant Acinetobacter baumannii patient isolates with diverse resistance mechanisms.
    J Antimicrob Chemother. 2025;80:2814-2824.
    >> Share

  100. ZAGHI I, Cricca M, Roberts JA, Brandolini M, et al
    Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria.
    J Antimicrob Chemother. 2025;80:2705-2713.
    >> Share

  101. SKOVMAND S, Norgaard C, Salado-Rasmussen K, Jensen JS, et al
    In vitro activity of thiamphenicol against drug-susceptible and drug-resistant strains of Mycoplasma genitalium.
    J Antimicrob Chemother. 2025;80:2676-2681.
    >> Share

    September 2025
  102. CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
    Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
    J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
    >> Share

  103. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
    Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
    J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
    >> Share

  104. GIARRATANA LR, Pirolo M, Roch FF, Conrady B, et al
    Evolving landscape of methicillin-resistant Staphylococcus pseudintermedius: the emergence of new epidemic waves across Europe, Asia and North America.
    J Antimicrob Chemother. 2025 Sep 27:dkaf340. doi: 10.1093.
    >> Share

  105. WITKOWSKA A, Biedrzycka M, Izdebski R, Literacka E, et al
    Assessment of an LC coupled with tandem MS (LC-MS/MS) tool in the detection of antimicrobial resistance mechanisms in Enterobacterales.
    J Antimicrob Chemother. 2025 Sep 24:dkaf339. doi: 10.1093.
    >> Share

  106. XU W, Yan P, Li Y, Sun B, et al
    The toxin-antitoxin system SavRS contributes to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus by mediating cell wall thickening.
    J Antimicrob Chemother. 2025 Sep 23:dkaf325. doi: 10.1093.
    >> Share

  107. ELADAWY M, Heslop N, Negus D, Thomas JC, et al
    Phenotype-genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt.
    J Antimicrob Chemother. 2025 Sep 23:dkaf352. doi: 10.1093.
    >> Share

  108. ZHU Y, Du S, Schwarz S, Hou J, et al
    Co-existence of the oxazolidinone resistance genes cfr and optrA on a novel multiresistance plasmid from a methicillin-resistant Macrococcoides bohemicum strain.
    J Antimicrob Chemother. 2025 Sep 22:dkaf333. doi: 10.1093.
    >> Share

  109. YANG P, Liu C, Zheng J, Yi J, et al
    Rapid replacement of blaKPC variant in ST11 carbapenem-resistant and hypervirulent Klebsiella pneumoniae contributed to ceftazidime/avibactam resistance during severe in vivo infection.
    J Antimicrob Chemother. 2025 Sep 18:dkaf337. doi: 10.1093.
    >> Share

  110. PAPAIOANNU BORJESSON R, Diotallevi S, Lolatto R, Cenderello G, et al
    Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.
    J Antimicrob Chemother. 2025;80:2369-2374.
    >> Share

  111. POCIUPANY M, Gillemot S, Georgala A, Snoeck R, et al
    Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient.
    J Antimicrob Chemother. 2025;80:2474-2483.
    >> Share

  112. NAIR S, Barker CR, Patel V, Poh CY, et al
    Highly drug-resistant Vibrio cholerae harbouring blaPER-7 isolated from travellers returning to England.
    J Antimicrob Chemother. 2025;80:2428-2432.
    >> Share

  113. LIU J, Yang X, Deng X, Hou M, et al
    Transmitted drug resistance profiles among people living with HIV-1 in Henan province, China, 2024.
    J Antimicrob Chemother. 2025;80:2496-2502.
    >> Share

  114. IMOLI D, Maingi JM, Mbae C, Kavai SM, et al
    Genomic characterization of multidrug-resistant extended-spectrum beta-lactamase-producing Vibrio cholerae O1 strains from 2022 cholera outbreak in Kenya.
    J Antimicrob Chemother. 2025;80:2399-2407.
    >> Share

    August 2025
  115. HAO J, Lu F, Chen P, Ji C, et al
    Characterization of blaOXA-542-mediated carbapenem resistance in Acinetobacter baumannii.
    J Antimicrob Chemother. 2025 Aug 29:dkaf311. doi: 10.1093.
    >> Share

  116. LI J, Hou W, Chang J, Tian X, et al
    The pivotal role of acnA in linking carbon metabolism to virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2025 Aug 28:dkaf317. doi: 10.1093.
    >> Share

  117. MCCRACKEN M, Walkty A, Adam HJ, Baxter M, et al
    Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  118. MATASEJE LF, Lerminiaux N, Lagace-Wiens P, Walkty A, et al
    Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  119. ADAM HJ, Golden AR, Martin I, Baxter MR, et al
    Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  120. BRAHAMI A, Karlowsky JA, McCracken M, Golding GR, et al
    Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  121. ZHANEL GG, Baxter MR, Lagace-Wiens P, Walkty A, et al
    Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  122. ZHANEL GG, Baxter MR, Golden AR, Lagace-Wiens P, et al
    Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  123. LAGACE-WIENS P, Mataseje L, McCracken M, Walkty A, et al
    Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.
    J Antimicrob Chemother. 2025;80.
    >> Share

  124. HURLEY JC, Madec JY
    The CANWARD studies: Canadian Antimicrobial Resistance Alliance (CARA) Canadian Hospital Ward Antibiotic Resistance Surveillance collection.
    J Antimicrob Chemother. 2025;80.
    >> Share

  125. SUN Y, McGiffin D, Ye L, Kostoulias X, et al
    Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections.
    J Antimicrob Chemother. 2025 Aug 26:dkaf316. doi: 10.1093.
    >> Share

  126. CERCENADO E, Marin M, Iglesias M, Jimenez L, et al
    Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.
    J Antimicrob Chemother. 2025 Aug 21:dkaf308. doi: 10.1093.
    >> Share

  127. MANCINI S, Seth-Smith HMB, Kolesnik-Goldmann N, Mermod M, et al
    Performance of disc diffusion and gradient strip test on different Mueller-Hinton agar media plates and ComASP(R) and Bruker UMIC(R) Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa
    J Antimicrob Chemother. 2025 Aug 18:dkaf301. doi: 10.1093.
    >> Share

  128. ZENG Q, Huang H, Lu J, Wu L, et al
    Comparative outcomes of polymyxins in neurocritical care patients with carbapenem-resistant Gram-negative bacterial pneumonia: a retrospective cohort study.
    J Antimicrob Chemother. 2025 Aug 7:dkaf295. doi: 10.1093.
    >> Share

  129. BALAKUNTLA J, Simjee S, Mane SP, Tice G, et al
    Distinct population structure and genomic context of NarAB between broiler and human clinical Enterococcus isolates.
    J Antimicrob Chemother. 2025 Aug 7:dkaf296. doi: 10.1093.
    >> Share

  130. ANASTASSOPOULOU C, Panagiotopoulos AP, Ferous S, Tsakris A, et al
    Phages connect the biological dots of antimicrobial resistance: from genesis and spread to alternative treatment modules.
    J Antimicrob Chemother. 2025 Aug 6:dkaf293. doi: 10.1093.
    >> Share

  131. GAGLIARDINI R, De Benedittis S, Tavelli A, Lapadula G, et al
    Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
    J Antimicrob Chemother. 2025;80:2169-2178.
    >> Share

  132. BRENCIANI A, Massacci FR, Albini E, Cucco L, et al
    Novel integrative and conjugative elements carrying cfr(B) and cfr(C) linezolid resistance genes in Clostridioides difficile isolates from calves, Italy.
    J Antimicrob Chemother. 2025;80:2280-2284.
    >> Share

  133. SADER HS, Kimbrough JH, Winkler ML, Castanheira M, et al
    Aztreonam/avibactam activity against Enterobacterales from European medical centres: summary of 5 years of surveillance prior to approval for clinical use (2019-2023).
    J Antimicrob Chemother. 2025;80:2070-2079.
    >> Share

  134. WATERA C, Da Silva JF, Namayanja G, Asio JN, et al
    HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022.
    J Antimicrob Chemother. 2025;80:2126-2134.
    >> Share

    July 2025
  135. FERRANDO ML, Saluzzo F, Frederiksen RF, Slettemeas JS, et al
    Determination of epidemiological cut-off values for Narasin, Salinomycin, Lasalocid and Monensin in Enterococcus faecium.
    J Antimicrob Chemother. 2025 Jul 31:dkaf113. doi: 10.1093.
    >> Share

  136. ABEGAZ FA, Al-Mir H, Kostyanev T, Prifti K, et al
    Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up.
    J Antimicrob Chemother. 2025 Jul 29:dkaf266. doi: 10.1093.
    >> Share

  137. CHEN X, Ouyang F, Wang N, Liu D, et al
    Synergistic effects of DHA27 combined with gentamicin against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
    J Antimicrob Chemother. 2025 Jul 25:dkaf239. doi: 10.1093.
    >> Share

  138. NODA M, Furuta A, Yashima S, Yaguchi D, et al
    Fluctuations in copy number of the class A carbapenemase gene blaFRI appear to confer high-level carbapenem resistance.
    J Antimicrob Chemother. 2025 Jul 25:dkaf258. doi: 10.1093.
    >> Share

  139. DEL MONTE M, Kaleci S, Chester J, Zerbato V, et al
    Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.
    J Antimicrob Chemother. 2025 Jul 22:dkaf242. doi: 10.1093.
    >> Share

  140. OU TH, Yang JL, Lin CY, Huang SH, et al
    Impact of empiric anti-VRE therapy on survival in vancomycin-resistant enterococcal bloodstream infection.
    J Antimicrob Chemother. 2025 Jul 17:dkaf225. doi: 10.1093.
    >> Share

  141. SINGH S, Adhikari S, Varshney N, Rani C, et al
    Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics.
    J Antimicrob Chemother. 2025 Jul 15:dkaf233. doi: 10.1093.
    >> Share

  142. MORAN RA, Hall RM
    The catA1 chloramphenicol resistance gene originated in Atlantibacter hermannii.
    J Antimicrob Chemother. 2025 Jul 11:dkaf227. doi: 10.1093.
    >> Share

  143. VAN DEN BIGGELAAR RHGA, Erdkamp D, de Visser AW, van den Eeden SJF, et al
    Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2025 Jul 1:dkaf198. doi: 10.1093.
    >> Share

  144. CHUA TP, Danielewski J, Bradshaw CS, Machalek DA, et al
    A novel azithromycin resistance mutation in Mycoplasma genitalium induced in vitro.
    J Antimicrob Chemother. 2025;80:2044-2050.
    >> Share

  145. PARANOS P, Siopi M, Papanikolaou E, Vourli S, et al
    Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations.
    J Antimicrob Chemother. 2025;80:1997-2006.
    >> Share

  146. LUO Z, Ning Y, Xiao M, Guo D, et al
    High azole non-wild type rates and nosocomial microsatellite typing aggregation of Wickerhamomyces anomalus in China according to a 12-year multicenter surveillance study.
    J Antimicrob Chemother. 2025;80:1964-1971.
    >> Share

  147. ZHAN Z, Cui Y, He S, Chang J, et al
    Molecular characteristics of chromosome-mediated colistin resistance in foodborne Salmonella isolates in China.
    J Antimicrob Chemother. 2025;80:1951-1963.
    >> Share

  148. KOONG J, Hall RM, Hamidian M
    Genomic characteristics of the multiresistant Acinetobacter baumannii global clone 1 reference strain A297/RUH875.
    J Antimicrob Chemother. 2025;80:1988-1992.
    >> Share

  149. ATTWOOD MLG, Noel A, Griffin P, Racine E, et al
    In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strains.
    J Antimicrob Chemother. 2025;80:1942-1946.
    >> Share

  150. DAVIDSON HC, Yau T, Dunstan I, Houston A, et al
    Early use of the novel antifungal rezafungin: a case series and literature review.
    J Antimicrob Chemother. 2025;80:1885-1892.
    >> Share

    June 2025
  151. LI J, He J, Huang Q
    Comment on: Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
    J Antimicrob Chemother. 2025 Jun 27:dkaf200. doi: 10.1093.
    >> Share

  152. QIU X, Tang J, Zhou J, Zhao X, et al
    Novel tmexC7D2-toprJ5 gene cluster and transposon Tn7759 carrying blaVIM-2 and blaOXA-10 genes in a carbapenem-resistant Pseudomonas putida from urban sewage.
    J Antimicrob Chemother. 2025 Jun 25:dkaf203. doi: 10.1093.
    >> Share

  153. AVCU G
    Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a Tertiary University Hospital-right to reply-author's response.
    J Antimicrob Chemother. 2025 Jun 25:dkaf201. doi: 10.1093.
    >> Share

  154. HONDA T, Vazquez-Montes MDLA, Fanshawe TR, Stoesser N, et al
    The impact of inter-infection time on antimicrobial resistance profiles in women with multiple urinary tract infections over time.
    J Antimicrob Chemother. 2025 Jun 24:dkaf194. doi: 10.1093.
    >> Share

  155. RASMUSSEN A, Hammerum AM, Hansen F, Soes LM, et al
    Carbapenem resistance in Escherichia marmotae: characterization of IncL plasmids carrying blaOXA-48.
    J Antimicrob Chemother. 2025 Jun 16:dkaf188. doi: 10.1093.
    >> Share

  156. ZHENG YD, Xu J, Wu J, Zhong T, et al
    Oleanolic acid derivative bardoxolone combats multidrug-resistant Staphylococcus aureus by destroying cell membrane and pyruvate metabolism pathway.
    J Antimicrob Chemother. 2025 Jun 10:dkaf190. doi: 10.1093.
    >> Share

  157. KIHLBERG P, Bech Johannesen T, Stegger M, Cajander S, et al
    Reliability of disc diffusion testing and molecular epidemiology of penicillin-susceptible Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2025 Jun 10:dkaf187. doi: 10.1093.
    >> Share

  158. EL NAGAR A, Dewe TCM, Broadfoot F, Teale C, et al
    Decreasing antimicrobial resistance in representative UK livestock species was associated with reduced total sales of antimicrobials in the last decade.
    J Antimicrob Chemother. 2025 Jun 5:dkaf145. doi: 10.1093.
    >> Share

  159. EDSLEV SM, Laurent F, Mansson E, Johannesen TB, et al
    Antibiotic resistance and population structure of Staphylococcus epidermidis from prosthetic joint infections in Sweden and France.
    J Antimicrob Chemother. 2025 Jun 3:dkaf166. doi: 10.1093.
    >> Share

  160. RUGEMALILA J, Ndege R, Kunambi P, Shabani S, et al
    Viral suppression after failure of PI-based ART among adolescents and youths with and without drug resistance mutations: a longitudinal analysis in Tanzania.
    J Antimicrob Chemother. 2025;80:1694-1701.
    >> Share

  161. HANDAL N, Kaspersen H, Mo SS, Cabanel N, et al
    A comparative study of the molecular characteristics of human uropathogenic Escherichia coli collected from two hospitals in Norway and France in 2019.
    J Antimicrob Chemother. 2025;80:1707-1715.
    >> Share

  162. ZHANG BL, Li H, Wang WX, Chen XZ, et al
    Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model.
    J Antimicrob Chemother. 2025;80:1613-1625.
    >> Share

  163. HAMZE H, Payne M, Stefanovic A, Lowe CF, et al
    Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada).
    J Antimicrob Chemother. 2025;80:1640-1646.
    >> Share

  164. RIPAMONTI D, Comi L, Francavilla A, Valenti D, et al
    Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study).
    J Antimicrob Chemother. 2025;80:1665-1672.
    >> Share

  165. LIN D, Zhang Y, Luo Z, Wang J, et al
    Unravelling the genetic contributors to linezolid resistance in Mycobacterium smegmatis: insights from a transposon library.
    J Antimicrob Chemother. 2025;80:1595-1603.
    >> Share

  166. SARIA P, Doulidis PG, Desvars-Larrive A, Toth AG, et al
    Pandemic human-associated extended-spectrum beta-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs.
    J Antimicrob Chemother. 2025;80:1573-1576.
    >> Share

    May 2025
  167. CHO H, Park KT
    A novel methicillin-resistant Staphylococcus aureus lineage (ST4174) with an uncharacterized SCCmec variant identified in Korean pigs.
    J Antimicrob Chemother. 2025 May 31:dkaf178. doi: 10.1093.
    >> Share

  168. CANAS MA, Garcia-de-la-Maria C, Garcia-Gonzalez J, Jimenez MP, et al
    Efficacy of linezolid in monotherapy q12h versus q8h versus combined with daptomycin in the treatment of experimental endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus strains.
    J Antimicrob Chemother. 2025 May 27:dkaf149. doi: 10.1093.
    >> Share

  169. KRISHNAPRASAD VH, Nayak V, Kumar S
    World Health Organisation's Bacterial Pathogen Priority List (BPPL) 2017 and BPPL 2024 to combat global antimicrobial resistance crisis: 'challenges and opportunities'.
    J Antimicrob Chemother. 2025 May 27:dkaf167. doi: 10.1093.
    >> Share

  170. HTAIK K, Vodstrcil LA, Plummer EL, Matthews LG, et al
    Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium.
    J Antimicrob Chemother. 2025 May 22:dkaf142. doi: 10.1093.
    >> Share

  171. BUTSCHEID Y, Frey PM, Pfister M, Pagani L, et al
    Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study.
    J Antimicrob Chemother. 2025 May 14:dkaf136. doi: 10.1093.
    >> Share

  172. VERA-YUNCA D, Matias C, Vingsbo Lundberg C, Friberg LE, et al
    Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.
    J Antimicrob Chemother. 2025 May 9:dkaf140. doi: 10.1093.
    >> Share

  173. SINGH R, Mukherjee S, Harrision LB, McDermott PF, et al
    Cross-resistance to 14-, 15- and 16-membered ring macrolides in Salmonella and Campylobacter.
    J Antimicrob Chemother. 2025;80:1445-1452.
    >> Share

    April 2025
  174. LOCKE JB, Andes D, Flanagan S, Redell M, et al
    Activity of rezafungin against Candida auris.
    J Antimicrob Chemother. 2025 Apr 30:dkaf124. doi: 10.1093.
    >> Share

  175. FIFER H, Johnson A
    The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment.
    J Antimicrob Chemother. 2025 Apr 10:dkaf109. doi: 10.1093.
    >> Share

  176. ORTONNE V, Bouvier-Alias M, Vo-Quang E, Cappy P, et al
    Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing.
    J Antimicrob Chemother. 2025;80:919-926.
    >> Share

  177. KOSTYANEV T, Al-Mir H, Prifti K, Rasmussen LB, et al
    External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.
    J Antimicrob Chemother. 2025;80:1037-1046.
    >> Share

  178. JAKUBU V, Cechova M, Musilek M, Malisova L, et al
    Amino acid substitutions in PBP3 in Haemophilus influenzae strains, their phenotypic detection and impact on resistance to beta-lactams.
    J Antimicrob Chemother. 2025;80:980-987.
    >> Share

  179. OMODING D, Musinguzi N, Boum Y 2nd, Muzoora C, et al
    Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda.
    J Antimicrob Chemother. 2025;80:955-961.
    >> Share

  180. REBELO AR, Bortolaia V, Leekitcharoenphon P, Hansen DS, et al
    One day in Denmark: whole-genome sequence-based analysis of Escherichia coli isolates from clinical settings.
    J Antimicrob Chemother. 2025;80:1011-1021.
    >> Share

  181. ZHENG YQ, Li QG, Latge JP, Tang XK, et al
    Potential risk of cross-resistance to voriconazole in HIV/AIDS patients with Talaromyces marneffei infection and the mechanisms of the cross-resistance.
    J Antimicrob Chemother. 2025;80:976-979.
    >> Share

  182. ALIDJINOU EK, Coulon P, Tetart M, Guigon A, et al
    Defective HIV-1 DNA pol sequences are not associated with HIV-1 DNA levels and drive most APOBEC-context drug resistance mutations.
    J Antimicrob Chemother. 2025;80:941-946.
    >> Share

  183. D'ANTONI ML, Falkard B, Andreatta K, Cox S, et al
    Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir.
    J Antimicrob Chemother. 2025;80:962-966.
    >> Share

  184. SHU Y, Liu J, Yang C, Li J, et al
    Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study.
    J Antimicrob Chemother. 2025;80:947-954.
    >> Share

    March 2025
  185. MANCINI S, Greiner M, Egli A, Nolte O, et al
    In vitro susceptibility testing of vancomycin-resistant Enterococcus faecium to fosfomycin.
    J Antimicrob Chemother. 2025 Mar 18:dkaf084. doi: 10.1093.
    >> Share

  186. SCHRODER D, Cherdtrakulkiat T, Doanh LH, Golparian D, et al
    Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gono
    J Antimicrob Chemother. 2025 Mar 18:dkaf066. doi: 10.1093.
    >> Share

  187. CINTHI M, Coccitto SN, Simoni S, Gherardi G, et al
    The optrA, cfr(D) and vanA genes are co-located on linear plasmids in linezolid- and vancomycin-resistant enterococcal clinical isolates in Italy.
    J Antimicrob Chemother. 2025 Mar 17:dkaf082. doi: 10.1093.
    >> Share

  188. PAGANO L, Fernandez OM
    Clinical aspects and recent advances in fungal diseases impacting human health.
    J Antimicrob Chemother. 2025;80.
    >> Share

  189. ARENDRUP MC, Cordonnier C
    Refractory versus resistant invasive aspergillosis.
    J Antimicrob Chemother. 2025;80.
    >> Share

  190. WU S, Zhang L, Luo X, Lin C, et al
    In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis.
    J Antimicrob Chemother. 2025 Mar 13:dkaf064. doi: 10.1093.
    >> Share

  191. LIU Q, Zhou X, Du Z, Wang X, et al
    Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report.
    J Antimicrob Chemother. 2025 Mar 11:dkaf069. doi: 10.1093.
    >> Share

  192. BRAND C, Newton-Foot M, Grobbelaar M, Whitelaw A, et al
    Antibiotic-induced stress responses in Gram-negative bacteria and their role in antibiotic resistance.
    J Antimicrob Chemother. 2025 Mar 7:dkaf068. doi: 10.1093.
    >> Share

  193. DING J, Hameed HMA, Long L, Zhang J, et al
    Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence.
    J Antimicrob Chemother. 2025;80:746-751.
    >> Share

  194. ABDI B, Saliba S, Wirden M, Faycal A, et al
    No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.
    J Antimicrob Chemother. 2025;80:810-816.
    >> Share

  195. KARADOGAN E, Sertcelik A, Dizman GT, Uzar H, et al
    A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2025;80:788-796.
    >> Share

  196. WIRDEN M, Abdi B, Lambert-Niclot S, Chaix ML, et al
    Major role of dolutegravir in the emergence of the S147G integrase resistance mutation.
    J Antimicrob Chemother. 2025;80:692-696.
    >> Share

  197. CHOGA OT, Lemogang GM, Choga WT, Muzanywa G, et al
    High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.
    J Antimicrob Chemother. 2025;80:767-776.
    >> Share

  198. CLEMENTE T, Diotallevi S, Minisci D, Di Biagio A, et al
    Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
    J Antimicrob Chemother. 2025;80:731-737.
    >> Share

  199. FAROOQ A, Martens M, Kroemer N, Pfaffendorf C, et al
    Pharmacokinetic/pharmacodynamic analysis of meropenem and fosfomycin combinations in in vitro time-kill and hollow-fibre infection models against multidrug-resistant and carbapenemase-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2025;80:701-712.
    >> Share

  200. SOULIE C, Agher R, Fauchois A, Abdi B, et al
    Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs.
    J Antimicrob Chemother. 2025;80:697-700.
    >> Share

  201. TOBIN LA, Abu Sabah E, Lebreton F, Myers GSA, et al
    Genomic analysis of early ST32 Acinetobacter baumannii strains recovered in US military treatment facilities reveals distinct lineages and links to the origins of the Tn6168 ampC transposon.
    J Antimicrob Chemother. 2025;80:666-675.
    >> Share

  202. MUSHTAQ S, Vickers A, Doumith M, Garello P, et al
    Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales.
    J Antimicrob Chemother. 2025;80:645-656.
    >> Share

    February 2025
  203. SERAPIDE F, Serraino R, Spadafora L, Bernardi M, et al
    Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.
    J Antimicrob Chemother. 2025 Feb 25:dkaf055. doi: 10.1093.
    >> Share

  204. LODHIA Z, Costa Da Silva J, Correia C, Cordeiro D, et al
    Surveying genetic markers of antibiotic resistance and genomic background in Chlamydia trachomatis: insights from a multiplex NGS-based approach in clinical strains from Portugal.
    J Antimicrob Chemother. 2025 Feb 17:dkaf036. doi: 10.1093.
    >> Share

  205. WERTH BJ, Zhang R, Barreras Beltran IA, Penewit K, et al
    Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials.
    J Antimicrob Chemother. 2025 Feb 12:dkaf042. doi: 10.1093.
    >> Share

  206. EDSLEV SM, Aarris M, Nielsen KL, Hertz FB, et al
    rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.
    J Antimicrob Chemother. 2025 Feb 6:dkaf035. doi: 10.1093.
    >> Share

  207. XING H, Zhang L, Li C, Schwarz S, et al
    Identification of a mepR mutation associated with tigecycline resistance in a clinical Staphylococcus aureus isolate.
    J Antimicrob Chemother. 2025 Feb 6:dkaf034. doi: 10.1093.
    >> Share

  208. BIANCO G, Boattini M, Lupo L, Ambretti S, et al
    In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study
    J Antimicrob Chemother. 2025;80:583-592.
    >> Share

  209. JO J, Kim SJ, Kwon KT, Ko KS, et al
    Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii.
    J Antimicrob Chemother. 2025;80:496-502.
    >> Share

  210. CUI XD, Liu SB, Wang RY, He DD, et al
    Investigation on the reversal effect of closantel on colistin resistance in MCR-1 positive Escherichia coli based on dose-response relationship.
    J Antimicrob Chemother. 2025;80:528-537.
    >> Share

  211. PAPAIOANNU BORJESSON R, Clemente T, Diotallevi S, Lolatto R, et al
    Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
    J Antimicrob Chemother. 2025;80:405-408.
    >> Share

  212. TUMBARELLO M, Giuliano G, Criscuolo M, Del Principe MI, et al
    Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.
    J Antimicrob Chemother. 2025;80:386-398.
    >> Share

    January 2025
  213. BITTERMAN R, Awwad A, Darawsha B, Dallashi H, et al
    Ceftaroline versus vancomycin for methicillin-resistant Staphylococcus aureus bacteraemia, a matched cohort study.
    J Antimicrob Chemother. 2025 Jan 28:dkaf009. doi: 10.1093.
    >> Share

  214. CADDEY B, Shaukat W, Tang KL, Barkema HW, et al
    Vancomycin-resistant Enterococcus prevalence and its association along the food chain: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2025 Jan 24:dkaf008. doi: 10.1093.
    >> Share


  215. Correction to: Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
    J Antimicrob Chemother. 2025 Jan 17:dkaf021. doi: 10.1093.
    >> Share

  216. OHEMU GP, Read C, Onwukwe CD, Olorunleke SO, et al
    Educate, Advocate, Act Now: a sustainable approach to combating antimicrobial resistance TODAY.
    J Antimicrob Chemother. 2025 Jan 7:dkae478. doi: 10.1093.
    >> Share

  217. MOREY F, Giron-Callejas A, Manzanero R, Urbina A, et al
    Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22.
    J Antimicrob Chemother. 2025;80:292-300.
    >> Share

  218. MELLO TP, Ramos LS, Andrade VV, Torres-Santos EC, et al
    Elucidating the augmented resistance profile of Scedosporium/Lomentospora species to azoles in a cystic fibrosis mimic environment.
    J Antimicrob Chemother. 2025;80:106-115.
    >> Share

  219. YANXIA S, Xuewei W, Gang L, Wei J, et al
    Analysis on characteristics and multilocus sequence typing of Clostridium perfringens in western China.
    J Antimicrob Chemother. 2025;80:216-226.
    >> Share

  220. CHEN S, Shang Y, Zheng J, Huo F, et al
    In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis.
    J Antimicrob Chemother. 2025;80:262-269.
    >> Share

  221. BALTAS I, Patel T, Soares AL
    Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
    J Antimicrob Chemother. 2025;80:59-67.
    >> Share

  222. HIRABAYASHI A, Yano H, Yahara K, Aoki S, et al
    Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan.
    J Antimicrob Chemother. 2025;80:192-199.
    >> Share

  223. ANDO N, Mizushima D, Takano M, Mitobe M, et al
    Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
    J Antimicrob Chemother. 2025;80:247-253.
    >> Share

  224. ROBERTSON A, Coutinho G, Mantzourani E, Szomolay B, et al
    Over-the-counter antibiotics compromising aminoglycoside activity.
    J Antimicrob Chemother. 2025;80:87-94.
    >> Share

  225. PARIONA JGM, Vasquez-Ponce F, Pariona EMM, Sousa-Carmo RR, et al
    Efficacy of meropenem against ceftazidime-avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114.
    J Antimicrob Chemother. 2025;80:162-168.
    >> Share

  226. MARCELIN AG, Soulie C, Wirden M, Barriere G, et al
    Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
    J Antimicrob Chemother. 2025;80:95-101.
    >> Share

    December 2024
  227. KIM SH, Kim HM, Chung DR, Ko JH, et al
    Synergistic effects of colistin-rifampin-based triple antimicrobial combination therapy against Carbapenem-resistant Pseudomonas aeruginosa: a time-kill assay.
    J Antimicrob Chemother. 2024 Dec 31:dkae466. doi: 10.1093.
    >> Share

  228. ERSOY SC, Madrigal SL, Proctor RA, Chambers HF, et al
    NaHCO3 modulates the bla operon and beta-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA).
    J Antimicrob Chemother. 2024 Dec 20:dkae455. doi: 10.1093.
    >> Share

  229. HANAI Y, Matsumoto K, Endo A, Hanawa K, et al
    Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study.
    J Antimicrob Chemother. 2024 Dec 17:dkae442. doi: 10.1093.
    >> Share

  230. ASSEFA GM, Roberts JA, Aslan AT, Mohammed SA, et al
    A systematic review and individual bacterial species level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria.
    J Antimicrob Chemother. 2024 Dec 17:dkae451. doi: 10.1093.
    >> Share

  231. DOELMAN TA, Adriaens N, Westerhuis BM, Bruisten SM, et al
    Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations.
    J Antimicrob Chemother. 2024 Dec 4:dkae430. doi: 10.1093.
    >> Share

  232. FIFER H, Doumith M, Rubinstein L, Mitchell L, et al
    Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.
    J Antimicrob Chemother. 2024;79:3332-3339.
    >> Share

  233. STERN A, Henig I, Cohen M, Gur I, et al
    Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.
    J Antimicrob Chemother. 2024;79:3289-3296.
    >> Share

  234. HUANG Y, Liao M, Hu X, Hu H, et al
    Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins.
    J Antimicrob Chemother. 2024;79:3210-3229.
    >> Share

  235. ALVAREZ C, Nastro M, Goyheneche B, Potente N, et al
    NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina.
    J Antimicrob Chemother. 2024;79:3174-3177.
    >> Share

    November 2024
  236. LEROY AG, Lemenand O, Thibaut S, Coeffic T, et al
    Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home-acquired urinary tract infections.
    J Antimicrob Chemother. 2024 Nov 29:dkae431. doi: 10.1093.
    >> Share

  237. LIU Q, Li S, Wang X, Lin Y, et al
    Comparative evaluation of eravacycline susceptibility testing methods in 587 clinical carbapenem-resistant Acinetobacter baumannii isolates: broth microdilution, MIC test strip and disc diffusion.
    J Antimicrob Chemother. 2024 Nov 21:dkae426. doi: 10.1093.
    >> Share

  238. MCGUIRE E, Ready D, Ellaby N, Potterill I, et al
    A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK.
    J Antimicrob Chemother. 2024 Nov 15:dkae419. doi: 10.1093.
    >> Share

  239. QIAN C, Hu P, Guo W, Han Y, et al
    Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.
    J Antimicrob Chemother. 2024;79:2965-2974.
    >> Share

  240. LODISE TP, Obi EN, Watanabe AH, Yucel E, et al
    Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2024;79:2954-2964.
    >> Share

  241. PARK J, Lee D, Yi H, Yun CW, et al
    Bacterial persistence to antibiotics activated by tRNA mutations.
    J Antimicrob Chemother. 2024;79:2923-2931.
    >> Share

  242. YANG F, Sun X, Fu Y, Zhao F, et al
    High-level ceftriaxone resistance due to transfer of penA allele 60.001 into endemic gonococcal lineages in Hangzhou, China.
    J Antimicrob Chemother. 2024;79:2854-2857.
    >> Share

    October 2024
  243. AVCU G, Erci E, Bilen NM, Ersayoglu I, et al
    Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.
    J Antimicrob Chemother. 2024 Oct 30:dkae387. doi: 10.1093.
    >> Share

  244. STURARO MC, de Souza GHA, Damaceno NDS, Silva ON, et al
    Antimicrobial activity of ceftibuten/polymyxin B combination against polymyxin/carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024 Oct 25:dkae382. doi: 10.1093.
    >> Share

  245. GHAHRAMANI A, Naghadian Moghaddam MM, Kianparsa J, Ahmadi MH, et al
    Overall status of carbapenem resistance among clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2024 Oct 11:dkae358. doi: 10.1093.
    >> Share

  246. YU L, Han X, Zhang W, Fu Y, et al
    The two-component sensor factor envZ influences antibiotic resistance and virulence in the evolutionary dynamics of multidrug-resistant Salmonella enteritidis causing multisite invasive infections.
    J Antimicrob Chemother. 2024 Oct 4:dkae355. doi: 10.1093.
    >> Share

  247. SIMJEE S, Weese JS, Singh R, Trott DJ, et al
    Redefining cross-resistance, co-resistance and co-selection: beyond confusion?
    J Antimicrob Chemother. 2024;79:2417-2420.
    >> Share

  248. ALIEVA KN, Golikova MV, Zinner SH
    Role of volume and inoculum in MIC assessment: a study with meropenem and Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024;79:2698-2707.
    >> Share

  249. HALLIDAY CL, Tay E, Green W, Law D, et al
    In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023.
    J Antimicrob Chemother. 2024;79:2611-2621.
    >> Share

  250. DAVIN-REGLI A, Pages JM, Vergalli J
    The contribution of porins to enterobacterial drug resistance.
    J Antimicrob Chemother. 2024;79:2460-2470.
    >> Share

  251. ZHANG XW, Song JJ, Zeng SH, Huang YL, et al
    Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections.
    J Antimicrob Chemother. 2024;79:2688-2697.
    >> Share

  252. GONZALEZ-PINTO L, Alonso-Garcia I, Blanco-Martin T, Camacho-Zamora P, et al
    Impact of chromosomally encoded resistance mechanisms and transferable beta-lactamases on the activity of cefiderocol and innovative beta-lactam/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2024;79:2591-2597.
    >> Share

  253. WANG Z, Jiang H, Pang X, Li J, et al
    Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
    J Antimicrob Chemother. 2024;79:2575-2585.
    >> Share

  254. ESCRIHUELA-VIDAL F, Fernandez-Hidalgo N, Munoz P, Villamarin M, et al
    Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort.
    J Antimicrob Chemother. 2024 Oct 1:dkae345. doi: 10.1093.
    >> Share

    September 2024
  255. SHAN X, Li C, Zhang L, Zou C, et al
    poxtA amplification and mutations in 23S rRNA confer enhanced linezolid resistance in Enterococcus faecalis.
    J Antimicrob Chemother. 2024 Sep 27:dkae342. doi: 10.1093.
    >> Share

  256. CORNU HEWITT B, Bossers A, van Kersen W, de Rooij MMT, et al
    Associations between acquired antimicrobial resistance genes in the upper respiratory tract and livestock farm exposures: a case-control study in COPD and non-COPD individuals.
    J Antimicrob Chemother. 2024 Sep 24:dkae335. doi: 10.1093.
    >> Share

  257. YANG W, Li X, Chen J, Zhang G, et al
    Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.
    J Antimicrob Chemother. 2024 Sep 24:dkae331. doi: 10.1093.
    >> Share

  258. DRYDEN M, Corley M, Wright N, Andrewin A, et al
    The United Nations' General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom's Overseas Territories.
    J Antimicrob Chemother. 2024 Sep 19:dkae330. doi: 10.1093.
    >> Share

  259. KARLOWSKY JA, Wise MG, Hackel MA, Six DA, et al
    Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
    J Antimicrob Chemother. 2024 Sep 17:dkae329. doi: 10.1093.
    >> Share

  260. KRUGER-HAKER H, Kostova V, Hanke D, Kaspar H, et al
    Genetic basis of macrolide resistance in porcine Pasteurella multocida isolates from the German national resistance monitoring program GERM-Vet 2008-2021.
    J Antimicrob Chemother. 2024 Sep 13:dkae316. doi: 10.1093.
    >> Share

  261. ABDELALL LM, Nagy YI, Kashef MT
    Restoring vancomycin activity against resistant Enterococcus faecalis using a transcription factor decoy as a vanA operon-inhibitor.
    J Antimicrob Chemother. 2024 Sep 10:dkae320. doi: 10.1093.
    >> Share

  262. WIDERSTROM R, Aarris M, Jacobsson S, Stegger M, et al
    Probing fosfomycin's potential: a study on susceptibility testing and resistance in Staphylococcus epidermidis from prosthetic joint infections.
    J Antimicrob Chemother. 2024 Sep 6:dkae312. doi: 10.1093.
    >> Share

  263. BOUTZOUKAS AE, Mackow N, Giri A, Komarow L, et al
    Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections.
    J Antimicrob Chemother. 2024 Sep 5:dkae306. doi: 10.1093.
    >> Share

  264. FABENI L, Armenia D, Abbate I, Gagliardini R, et al
    HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
    J Antimicrob Chemother. 2024;79:2152-2162.
    >> Share

  265. ARMENIA D, Spagnuolo V, Bellocchi MC, Galli L, et al
    Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry.
    J Antimicrob Chemother. 2024;79:2354-2363.
    >> Share

  266. DAVID A, Golparian D, Jacobsson S, Stratton C, et al
    In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions.
    J Antimicrob Chemother. 2024;79:2221-2226.
    >> Share

  267. MAZZITELLI M, Pontillo D, Clemente T, Di Biagio A, et al
    Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry.
    J Antimicrob Chemother. 2024;79:2163-2169.
    >> Share

  268. GLEN KA, Lamont IL
    Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to beta-lactams but inhibit cell division.
    J Antimicrob Chemother. 2024;79:2170-2178.
    >> Share

  269. DIZI ISIK A, Akkoc G, Ergenc Z, Yilmaz S, et al
    The use of fosfomycin in infections caused by multidrug-resistant pathogens, especially pneumonia in children: a five-year retrospective single-centre experience.
    J Antimicrob Chemother. 2024;79:2179-2185.
    >> Share

  270. ABOUELHASSAN Y, Nicolau DP, Abdelraouf K
    Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy.
    J Antimicrob Chemother. 2024;79:2306-2316.
    >> Share

    August 2024
  271. PAPOUSKOVA A, Drabkova Z, Brajerova M, Krutova M, et al
    The circulation of methicillin-resistant Staphylococcus aureus between humans, horses and the environment at the equine clinic.
    J Antimicrob Chemother. 2024 Aug 30:dkae303. doi: 10.1093.
    >> Share

  272. COUTO F, Martins I, Vale F, Domingues F, et al
    Insights into macrolide resistance in Arcobacter butzleri: potential resistance mechanisms and impact on bacterial fitness and virulence.
    J Antimicrob Chemother. 2024 Aug 19:dkae287. doi: 10.1093.
    >> Share

  273. LUZARRAGA V, Cremniter J, Plouzeau C, Michaud A, et al
    In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.
    J Antimicrob Chemother. 2024 Aug 10:dkae269. doi: 10.1093.
    >> Share


  274. Correction to: Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
    J Antimicrob Chemother. 2024 Aug 6:dkae289. doi: 10.1093.
    >> Share

  275. MEIJS AP, Chaname-Pinedo LE, Deng H, Veldman KT, et al
    Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009-2020.
    J Antimicrob Chemother. 2024 Aug 2:dkae268. doi: 10.1093.
    >> Share

  276. SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
    Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21.
    J Antimicrob Chemother. 2024 Aug 2:dkae272. doi: 10.1093.
    >> Share

  277. UNEMO M, Sanchez-Buso L, Golparian D, Jacobsson S, et al
    The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
    J Antimicrob Chemother. 2024;79:1885-1899.
    >> Share

  278. SOULIE C, Balde A, Fofana D, Charpentier C, et al
    DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.
    J Antimicrob Chemother. 2024;79:1974-1984.
    >> Share

  279. BUCZKOWSKA M, Chattaway MA, Jenkins C, Hungerford D, et al
    Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action.
    J Antimicrob Chemother. 2024;79:1811-1819.
    >> Share

  280. LEE R, Nho D, Cho SY, Park S, et al
    Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis.
    J Antimicrob Chemother. 2024;79:1998-2007.
    >> Share

  281. ZHANG X, Zeng W, Kong J, Huang Z, et al
    The prevalence and mechanisms of heteroresistance to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024;79:1865-1876.
    >> Share

  282. DWIBEDY SK, Padhy I, Panda AK, Mohapatra SS, et al
    Prevalence of polymyxin-resistant bacterial strains in India: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2024;79:1762-1774.
    >> Share

  283. YANG Q, Li L, Zhao G, Cui Q, et al
    Characterization of a multiresistance optrA- and lsa(E)-harbouring unconventional circularizable structure in Streptococcus suis.
    J Antimicrob Chemother. 2024 Aug 1:dkae250. doi: 10.1093.
    >> Share

    July 2024
  284. THANASAK J, Wongsurawat T, Jenjaroenpun P, Phumthanakorn N, et al
    Characterization of staphylococcal cassette chromosome mec in Staphylococcus haemolyticus ST3 and ST42 isolates from bovine mastitis milk: identification of novel variant in class C1 mec complex.
    J Antimicrob Chemother. 2024 Jul 31:dkae242. doi: 10.1093.
    >> Share

  285. HOWARD A, Green PL, Velluva A, Gerada A, et al
    Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study.
    J Antimicrob Chemother. 2024 Jul 25:dkae230. doi: 10.1093.
    >> Share

  286. ZHOU X, Yang M, Chen F, Wang L, et al
    Prediction of antimicrobial resistance in Klebsiella pneumoniae using genomic and metagenomic next-generation sequencing data.
    J Antimicrob Chemother. 2024 Jul 19:dkae248. doi: 10.1093.
    >> Share

  287. SHI Q, Ruan Z, Zhang P, Hu H, et al
    Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study.
    J Antimicrob Chemother. 2024 Jul 13:dkae227. doi: 10.1093.
    >> Share

  288. ZHOU H, Buetti N, Perez-Galera S, Bravo-Ferrer J, et al
    Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
    J Antimicrob Chemother. 2024 Jul 11:dkae157. doi: 10.1093.
    >> Share

  289. SHEEHY J, Scott AP, Henden AS, Kennedy G, et al
    Low rates of complications and beta-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
    J Antimicrob Chemother. 2024 Jul 8:dkae209. doi: 10.1093.
    >> Share

  290. SWINKELS AF, Berendsen BJA, Fischer EAJ, Zomer AL, et al
    Extended period of selection for antimicrobial resistance due to recirculation of persistent antimicrobials in broilers.
    J Antimicrob Chemother. 2024 Jul 2:dkae213. doi: 10.1093.
    >> Share

  291. VALDEZATE S, Medina-Pascual MJ, Villalon P, Garrido N, et al
    Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
    J Antimicrob Chemother. 2024;79:1683-1687.
    >> Share

  292. DAABOUL D, Osman M, Kassem II, Yassine I, et al
    Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    J Antimicrob Chemother. 2024;79:1614-1618.
    >> Share

  293. TEYSSOU E, Soulie C, Fauchois A, Palich R, et al
    The RT M184V resistance mutation clearance in the reservoir is mainly related to CD4 nadir and viral load zenith independently of therapeutic regimen type.
    J Antimicrob Chemother. 2024;79:1673-1676.
    >> Share

  294. SCHMID PJ, Forstner P, Kittinger C
    Sliding motility of Bacillus cereus mediates vancomycin pseudo-resistance during antimicrobial susceptibility testing.
    J Antimicrob Chemother. 2024;79:1628-1636.
    >> Share

  295. IVANOVA M, Ovsepian A, Leekitcharoenphon P, Seyfarth AM, et al
    Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
    J Antimicrob Chemother. 2024;79:1657-1667.
    >> Share

  296. CHEN PJ, Tan MC, Huang WC, Hsu SY, et al
    The individual contributions of blaB, blaGOB and blaCME on MICs of beta-lactams in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2024;79:1577-1580.
    >> Share

  297. ELBEDIWI M, Rolff J
    Metabolic pathways and antimicrobial peptide resistance in bacteria.
    J Antimicrob Chemother. 2024;79:1473-1483.
    >> Share

  298. WIRDEN M, Pouderoux C, Peytavin G, Abdi B, et al
    Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir.
    J Antimicrob Chemother. 2024;79:1706-1707.
    >> Share

  299. CADENAS-JIMENEZ I, Saiz-Escobedo L, Carrera-Salinas A, Camprubi-Marquez X, et al
    Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21).
    J Antimicrob Chemother. 2024 Jul 1:dkae214. doi: 10.1093.
    >> Share

    June 2024
  300. CHEN PY, Huang YS, Chuang YC, Wang JT, et al
    Implication of genotypes for prognosis of Candida glabrata bloodstream infections.
    J Antimicrob Chemother. 2024 Jun 22:dkae200. doi: 10.1093.
    >> Share

  301. WANG P, Liu S, He X, Miao W, et al
    Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection.
    J Antimicrob Chemother. 2024 Jun 13:dkae193. doi: 10.1093.
    >> Share

  302. WESTON G, Giri A, Komarow L, Ge L, et al
    Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2024 Jun 12:dkae186. doi: 10.1093.
    >> Share

  303. CHANCHAITHONG P, Chueahiran S, Pinpimai K, Sroithongkham P, et al
    Chromosomal and plasmid localization of ileS2 in high-level mupirocin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus isolated from canine and feline origins.
    J Antimicrob Chemother. 2024 Jun 12:dkae172. doi: 10.1093.
    >> Share

  304. ALTARAWNEH H, Alhomra T, Alharbi M, Fan Y, et al
    Synergistic bactericidal activity of a novel dual beta-lactam combination against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Jun 4:dkae165. doi: 10.1093.
    >> Share

  305. RAHMAT ULLAH S, Jamal M, Rahman A, Andleeb S, et al
    Comprehensive insights into Klebsiella pneumoniae: unravelling clinical impact, epidemiological trends and antibiotic-resistance challenges.
    J Antimicrob Chemother. 2024 Jun 4:dkae184. doi: 10.1093.
    >> Share

  306. MARURI-ARANSOLO A, Lopez-Causape C, Hernandez-Garcia M, Garcia-Castillo M, et al
    In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
    J Antimicrob Chemother. 2024;79:1432-1440.
    >> Share

  307. LIU M, Wang M, Huang M, Gao Q, et al
    Iron efflux by IetA enhances beta-lactam aztreonam resistance and is linked to oxidative stress through cellular respiration in Riemerella anatipestifer.
    J Antimicrob Chemother. 2024;79:1385-1396.
    >> Share

  308. NAVICKAITE I, Holmes H, Dondi L, Randall L, et al
    Occurrence and characterization of rmtB-harbouring Salmonella and Escherichia coli isolates from a pig farm in the UK.
    J Antimicrob Chemother. 2024;79:1329-1336.
    >> Share

  309. KOLTE B, Nubel U
    Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    J Antimicrob Chemother. 2024;79:1320-1328.
    >> Share

  310. WANGCHINDA W, Pogue JM, Thamlikitkul V, Leelawattanachai P, et al
    Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2024;79:1372-1379.
    >> Share

  311. ZOU C, Xu C, Yu R, Shan X, et al
    Tandem amplification of a plasmid-borne tet(A) variant gene confers tigecycline resistance in Escherichia coli.
    J Antimicrob Chemother. 2024;79:1294-1302.
    >> Share

  312. NISSIM Y, LaSala PR, Slain D
    A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales.
    J Antimicrob Chemother. 2024;79:1463-1466.
    >> Share

  313. TOLLEY A, Bansal A, Murerwa R, Howard Dicks J, et al
    Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
    J Antimicrob Chemother. 2024;79:1248-1269.
    >> Share

    May 2024
  314. GALAL L, Mohamed HS, Dupont C, Conquet G, et al
    Circulation of hypervirulent carbapenem-resistant Klebsiella pneumoniae in humans and fish in Djibouti.
    J Antimicrob Chemother. 2024 May 22:dkae144. doi: 10.1093.
    >> Share

  315. LEE YL, Wang WY, Ko WC, Hsueh PR, et al
    Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
    J Antimicrob Chemother. 2024 May 17:dkae140. doi: 10.1093.
    >> Share

  316. MILLS RO, Dadzie I, Le-Viet T, Baker DJ, et al
    Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
    J Antimicrob Chemother. 2024 May 16:dkae123. doi: 10.1093.
    >> Share

  317. HARMER CJ, Nelson MJ, Lebreton F, Lertsethtakarn P, et al
    Distribution and expression of the aac(6')-Im (aacA16) aminoglycoside resistance gene.
    J Antimicrob Chemother. 2024 May 14:dkae136. doi: 10.1093.
    >> Share

  318. BUZON-MARTIN L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L, et al
    Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.
    J Antimicrob Chemother. 2024;79:1153-1156.
    >> Share

  319. PANG X, He Q, Tang K, Huang J, et al
    Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
    J Antimicrob Chemother. 2024;79:1142-1152.
    >> Share

  320. CHEN GJ, Cheng CY, Yang CJ, Lee NY, et al
    Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
    J Antimicrob Chemother. 2024;79:1157-1163.
    >> Share

  321. AGHOKENG AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, et al
    Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
    J Antimicrob Chemother. 2024;79:1164-1168.
    >> Share

  322. GALANI I, Souli M, Katsala D, Karaiskos I, et al
    In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
    J Antimicrob Chemother. 2024;79:1101-1108.
    >> Share

  323. MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
    Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
    J Antimicrob Chemother. 2024;79:1051-1059.
    >> Share

  324. UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
    Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    J Antimicrob Chemother. 2024;79:1006-1013.
    >> Share

    April 2024
  325. WANGCHINDA W, Kaye KS, Patel TS, Albin OR, et al
    A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended beta-lactam-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2024 Apr 6:dkae104. doi: 10.1093.
    >> Share

  326. MACFADYEN AC, Paterson GK
    Methicillin resistance in Staphylococcus pseudintermedius encoded within novel staphylococcal cassette chromosome mec (SCCmec) variants.
    J Antimicrob Chemother. 2024 Apr 2:dkae096. doi: 10.1093.
    >> Share

    March 2024
  327. HARMER CJ, Cahill SM, Kenyon JJ, Hall RM, et al
    Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome.
    J Antimicrob Chemother. 2024 Mar 26:dkae064. doi: 10.1093.
    >> Share

  328. GOLPARIAN D, Bazzo ML, Ahlstrand J, Schorner MA, et al
    Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
    J Antimicrob Chemother. 2024 Mar 22:dkae075. doi: 10.1093.
    >> Share

  329. PITT-KENDALL R, Sun S, Hughes S, Merrick R, et al
    Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016-20.
    J Antimicrob Chemother. 2024 Mar 22:dkae073. doi: 10.1093.
    >> Share

  330. TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
    Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
    J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
    >> Share

  331. PHILIP A, Oueslati S, Villa F, Pannetier C, et al
    Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
    J Antimicrob Chemother. 2024 Mar 19:dkae062. doi: 10.1093.
    >> Share

  332. KITTL S, Brodard I, Tresch M, Perreten V, et al
    Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid.
    J Antimicrob Chemother. 2024 Mar 18:dkae066. doi: 10.1093.
    >> Share

  333. ANJUM MF, Duggett N, Sheldon E, Sharma M, et al
    Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter.
    J Antimicrob Chemother. 2024 Mar 5:dkae052. doi: 10.1093.
    >> Share

  334. REZZOUG I, Emeraud C, Girlich D, Creton E, et al
    Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.
    J Antimicrob Chemother. 2024;79:683-685.
    >> Share

    February 2024
  335. VAN HAL SJ, Jensen SO, Tong SYC, Bentley S, et al
    Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Feb 27:dkae048. doi: 10.1093.
    >> Share

  336. JACQUELINE C, Samper-Cativiela C, Monzon Fernandez S, Ugarte-Ruiz M, et al
    Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021.
    J Antimicrob Chemother. 2024 Feb 16:dkae029. doi: 10.1093.
    >> Share

  337. XU Y, Luo X, Yuan B, Liang P, et al
    The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.
    J Antimicrob Chemother. 2024 Feb 15:dkae035. doi: 10.1093.
    >> Share

  338. BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
    Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA.
    J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
    >> Share

  339. HELBO T, Boel JB, Bartels MD, Ahlstrom MG, et al
    Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
    J Antimicrob Chemother. 2024 Feb 9:dkae036. doi: 10.1093.
    >> Share

  340. SOMAJO S, Nilsson F, Ekelund O, Unemo M, et al
    Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
    J Antimicrob Chemother. 2024 Feb 9:dkae034. doi: 10.1093.
    >> Share

  341. ROY S, Morita D, Bhattacharya S, Dutta S, et al
    Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India.
    J Antimicrob Chemother. 2024 Feb 9:dkae024. doi: 10.1093.
    >> Share

  342. ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
    Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
    J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
    >> Share

  343. MCHUGH MP, Pettigrew KA, Taori S, Evans TJ, et al
    Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 2024 Feb 7:dkae023. doi: 10.1093.
    >> Share

  344. AULICINO PC, Sharma S, Truong K, Kukunoor V, et al
    Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy.
    J Antimicrob Chemother. 2024;79:370-374.
    >> Share

  345. HU EW, Lu HF, Lin YT, Yang TC, et al
    Modulatory role of SmeQ in SmeYZ efflux pump-involved functions in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2024;79:383-390.
    >> Share

  346. NDUVA GM, Otieno F, Kimani J, Sein Y, et al
    Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
    J Antimicrob Chemother. 2024;79:287-296.
    >> Share

  347. FERRARIS L, Delannoy J, Mazuet C, Diancourt L, et al
    Clostridium neonatale antimicrobial susceptibility, genetic resistance determinants, and genotyping: a multicentre spatiotemporal retrospective analysis.
    J Antimicrob Chemother. 2024;79:271-279.
    >> Share

  348. HOSAKA Y, Muraki Y, Kajihara T, Kawakami S, et al
    Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
    J Antimicrob Chemother. 2024;79:312-319.
    >> Share

    January 2024
  349. FINDLAY J, Bianco G, Boattini M, Nordmann P, et al
    In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA.
    J Antimicrob Chemother. 2024 Jan 31:dkae018. doi: 10.1093.
    >> Share

  350. WASAN H, Reeta KH, Gupta YK
    Strategies to improve antibiotic access and a way forward for lower middle-income countries.
    J Antimicrob Chemother. 2024;79:1-10.
    >> Share

  351. RITCHIE G, Chorlton SD, Matic N, Bilawka J, et al
    WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
    J Antimicrob Chemother. 2024;79:55-60.
    >> Share

  352. QI Q, Ghaly TM, Rajabal V, Gillings MR, et al
    Dissecting molecular evolution of class 1 integron gene cassettes and identifying their bacterial hosts in suburban creeks via epicPCR.
    J Antimicrob Chemother. 2024;79:100-111.
    >> Share

    December 2023
  353. GILL CM, Santini D, Nicolau DP
    In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
    J Antimicrob Chemother. 2023 Dec 28:dkad396. doi: 10.1093.
    >> Share

  354. XU C, Li Y, Li Y, Huang L, et al
    Characterization of an ST38 carbapenem-resistant and highly virulent Escherichia coli carrying conjugatively transferable ColV virulence-resistance and blaNDM-5-positive resistance plasmids.
    J Antimicrob Chemother. 2023 Dec 28:dkad403. doi: 10.1093.
    >> Share

  355. MASSACCI FR, Cucco L, Paniccia M, Luppi A, et al
    Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin.
    J Antimicrob Chemother. 2023 Dec 28:dkad395. doi: 10.1093.
    >> Share

  356. ZHAO M, He S, Wen R, Li C, et al
    Membrane vesicles derived from Enterococcus faecalis promote the co-transfer of important antibiotic resistance genes located on both plasmids and chromosomes.
    J Antimicrob Chemother. 2023 Dec 18:dkad381. doi: 10.1093.
    >> Share

  357. ERTL NG, Anderson TK, Pardo CJ, Maidment TI, et al
    Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
    J Antimicrob Chemother. 2023 Dec 15:dkad373. doi: 10.1093.
    >> Share

  358. SHENG Q, Wang N, Zhou Y, Deng X, et al
    A new function of thymol nanoemulsion for reversing colistin resistance in Salmonella enterica serovar Typhimurium infection.
    J Antimicrob Chemother. 2023;78:2983-2994.
    >> Share

  359. DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
    Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemia.
    J Antimicrob Chemother. 2023;78:2938-2942.
    >> Share

  360. UNO S, Gatanaga H, Hayashida T, Imahashi M, et al
    Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.
    J Antimicrob Chemother. 2023;78:2859-2868.
    >> Share

  361. MACGOWAN AP, Attwood MLG, Noel AR, Barber R, et al
    Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance.
    J Antimicrob Chemother. 2023;78:2869-2877.
    >> Share

    November 2023
  362. JIANG N, Chen H, Cheng L, Fu Q, et al
    Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China.
    J Antimicrob Chemother. 2023 Nov 29:dkad365. doi: 10.1093.
    >> Share

  363. BOU-ANTOUN S, Rokadiya S, Ashiru-Oredope D, Demirjian A, et al
    COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
    J Antimicrob Chemother. 2023;78.
    >> Share

  364. LEFRANC M, Accoceberry I, Fitton-Ouhabi V, Biteau N, et al
    Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
    J Antimicrob Chemother. 2023 Nov 22:dkad359. doi: 10.1093.
    >> Share

  365. NING YT, Sun TS, Dai RC, Luo ZY, et al
    Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China.
    J Antimicrob Chemother. 2023 Nov 22:dkad356. doi: 10.1093.
    >> Share

  366. DAI X, Sun J, Zhao W, Wang J, et al
    Emergence of a novel ISS1N-optrA-carrying transposon within an integrative and conjugative element from Streptococcus parasuis.
    J Antimicrob Chemother. 2023 Nov 15:dkad347. doi: 10.1093.
    >> Share

  367. LODISE TP, Yucel E, Obi EN, Watanabe AH, et al
    Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer beta-lactam or beta-lactam/beta-lactamase inhib
    J Antimicrob Chemother. 2023 Nov 14:dkad351. doi: 10.1093.
    >> Share

  368. LI J, Song Y, Deng J, Wang Z, et al
    Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
    J Antimicrob Chemother. 2023 Nov 7:dkad307. doi: 10.1093.
    >> Share

  369. LI M, Song C, Hu J, Dong A, et al
    Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.
    J Antimicrob Chemother. 2023;78:2743-2751.
    >> Share

  370. FUNICIELLO E, Mula J, Mignone F, Silvestro E, et al
    Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis.
    J Antimicrob Chemother. 2023;78:2776-2778.
    >> Share

    October 2023
  371. TRUSWELL A, Lee ZZ, Stegger M, Blinco J, et al
    Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry.
    J Antimicrob Chemother. 2023 Oct 21:dkad323. doi: 10.1093.
    >> Share

  372. CALADO NOGUEIRA DE MOURA V, Nguyen MH, Hunkins JJ, Daley CL, et al
    In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
    J Antimicrob Chemother. 2023 Oct 21:dkad317. doi: 10.1093.
    >> Share

  373. LEE SY, Gill CM, Nicolau DP
    Activity of novel beta-lactam/beta-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2023 Oct 16:dkad225. doi: 10.1093.
    >> Share

  374. CINTHI M, Coccitto SN, Simoni S, Zeni G, et al
    Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain.
    J Antimicrob Chemother. 2023 Oct 14:dkad321. doi: 10.1093.
    >> Share

  375. HALLIDAY C, Kim HY, Tay E, Chen SCA, et al
    Exploring synergy between azole antifungal drugs and statins for Candida auris.
    J Antimicrob Chemother. 2023 Oct 12:dkad303. doi: 10.1093.
    >> Share

  376. PICCICA M, Spinicci M, Botta A, Bianco V, et al
    Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
    J Antimicrob Chemother. 2023 Oct 9:dkad298. doi: 10.1093.
    >> Share

  377. CHEN Y, Yong M, Li M, Si Z, et al
    A hydrophilic polyimidazolium antibiotic targeting the membranes of Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:2581-2590.
    >> Share

  378. MARUAPULA D, Moraka NO, Bareng OT, Mokgethi PT, et al
    Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
    J Antimicrob Chemother. 2023;78:2489-2495.
    >> Share

    September 2023

  379. Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
    J Antimicrob Chemother. 2023 Sep 14:dkad282. doi: 10.1093.
    >> Share

  380. JAHA B, Schenkel CD, Jorimann L, Huber M, et al
    Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
    J Antimicrob Chemother. 2023;78:2323-2334.
    >> Share

  381. VAN HAL SJ, Whiley DM, Le T, Ray S, et al
    Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
    J Antimicrob Chemother. 2023;78:2203-2208.
    >> Share

    July 2023
  382. BENDER JK, Baufeld E, Becker K, Claus H, et al
    CHROMAgar LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.
    J Antimicrob Chemother. 2023 Jul 20:dkad218. doi: 10.1093.
    >> Share

    June 2023
  383. SIMJEE S, Tice G
    The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
    J Antimicrob Chemother. 2023 Jun 9:dkad183. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016